Targeting RIPK1,2,3 to combat inflammation.

Site
Oxford
Pubmed id
26472031
Authors

Bullock AN, Degterev A

DOI
10.18632/oncotarget.6106
Journal
Oncotarget
Publication Date
2015-10-13
Year
2015
N Publication Date
Validated
Y